AVGR stock forecast
Our latest prediction for Avinger, Inc.'s stock price was made on the Nov. 15, 2017 when the stock price was at 9.12$.
In the short term (2weeks), AVGR's stock price should underperform the market by -1.08%. During that period the price should oscillate between -13.71% and +24.12%.
In the medium term (3months), AVGR's stock price should underperform the market by -4.15%. During that period the price should oscillate between -27.24% and +65.93%.Get email alerts
About Avinger, Inc.
Avinger, Inc. manufactures catheter devices used to treat vascular diseases. It designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. Its products include Pantheris, Lightbox, Ocelot, Ocelot MVRX, Ocelot PIXL, Pantheris, Wildcat, Juicebox and Kittycat 2. The company offers its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger was founded by John B. Simpson and Himanshu N. Patel on March 8, 2007 and is headquartered in Redwood City, CA.
At the moment the company generates 7M USD in revenues.
On its last earning announcement, the company reported a loss of -14.74$ per share.
The book value per share is 0.56$
Three months stock forecastNov. 15, 2017
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|